Sex differences in adverse event reporting in SWOG chemotherapy, biologic/immunotherapy, and targeted agent cancer clinical trials.

被引：0

作者：

Unger, Joseph M.

Vaidya, Riha

Albain, Kathy S.

LeBlanc, Michael Leo

Minasian, Lori M.

Gotay, Carolyn

Henry, Norah Lynn

Fisch, Michael Jordan

Ramsey, Scott David

Blanke, Charles David

Lyman, Gary H.

Hershman, Dawn L.

机构：

[1] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA

[2] Loyola Univ Chicago, Cardinal Bernardin Canc Ctr, Stritch Sch Med, Maywood, IL 60153 USA

[3] Southwest Oncol Grp, Stat Ctr, Seattle, WA USA

[4] NCI, Rockville, MD USA

[5] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada

[6] Univ Utah, Salt Lake City, UT USA

[7] AIM Specialty Hlth, Chicago, IL USA

[8] Oregon Hlth & Sci Univ, Portland, OR 97201 USA

[9] Columbia Univ, Med Ctr, New York, NY USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

11588

引用

页数：1

共 27 条

[1] Sex Differences in Risk of Severe Adverse Events in Patients Receiving Immunotherapy, Targeted Therapy, or Chemotherapy in Cancer Clinical Trials
Unger, Joseph M.
Vaidya, Riha
Albain, Kathy S.
LeBlanc, Michael
Minasian, Lori M.
Gotay, Carolyn C.
Henry, N. Lynn
Fisch, Michael J.
Lee, Shing M.
Blanke, Charles D.
Hershman, Dawn L.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (13) : 1474 - +
[2] Sex differences in severe adverse events in patients receiving immunotherapy, targeted therapy, or chemotherapy in Cancer clinical trials: An evidentiary perspective
Unger, Joseph M.
Hershman, Dawn L.
[J]. CANCER RESEARCH, 2023, 83 (07)
[3] ELICITING THE CHILD'S VOICE IN ADVERSE EVENT REPORTING IN ONCOLOGY CLINICAL TRIALS.
Hinds, Pamela
Reeve, Bryce
Jaobs, Shana
Baker, Justin
Mack, Jenny
Withycom, Janice
[J]. ONCOLOGY NURSING FORUM, 2017, 44 (02)
[4] Systematic review of adverse events reporting in clinical trials leading to approval of targeted therapy and immunotherapy
Bossi, P.
Botta, L.
Bironzo, P.
Sonetto, C.
Musettini, G.
Sbrana, A.
Di Giannantonio, V.
Locati, L.
Di Maio, M.
Antonuzzo, A.
[J]. ANNALS OF ONCOLOGY, 2016, 27
[5] Systematic review of adverse events reporting in clinical trials leading to approval of targeted therapy and immunotherapy
Antonuzzo, A.
Bossi, P.
Botta, L.
Bironzo, P.
Sonetto, C.
Musettini, G.
Sbrana, A.
Di Giannantonio, V.
Locati, L.
Di Maio, M.
[J]. ANNALS OF ONCOLOGY, 2016, 27
[6] Systematic Review of adverse events reporting in clinical trials leading to approval of targeted therapy and immunotherapy
Bossi, Paolo
Botta, Laura
Bironzo, Paolo
Sonetto, Cristina
Musettini, Gianna
Sbrana, Andrea
Di Giannantonio, Valerio
Locati, Laura D.
Di Maio, Massimo
Antonuzzo, Andrea
[J]. FUTURE ONCOLOGY, 2019, 15 (21) : 2543 - 2553
[7] Geographic variation in adverse event reporting patterns in breast cancer clinical trials
Gonzalez, Valeria
Machado, Andres
Fung, Helena
Spera, Gonzalo
Meyer, Carlos
Millan, Pablo
Mackey, John R.
Fresco, Rodrigo
[J]. CANCER RESEARCH, 2018, 78 (04)
[8] Adverse event reporting in publications compared with sponsor database for cancer clinical trials
Scharf, Orit
Colevas, A. Dimitrios
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (24) : 3933 - 3938
[9] Prevalence of Adverse Event Reporting in Adolescents and Young Adults Enrolled in Cancer Clinical Trials
Wayant, Cole
Fitzgerald, Kyle
Hemmerich, Christian
Geng, Yimin
Freyer, David
Roth, Michael
[J]. JCO ONCOLOGY PRACTICE, 2023, 19 (11) : 1048 - +
[10] Adverse event load, onset, and maximum grade: A novel method of reporting adverse events in cancer clinical trials
Lopes, Guilherme S.
Tournigand, Christophe
Olswold, Curtis L.
Cohen, Romain
Kempf, Emmanuelle
Saltz, Leonard
Goldberg, Richard M.
Hurwitz, Herbert
Fuchs, Charles
de Gramont, Aimery
Shi, Qian
[J]. CLINICAL TRIALS, 2021, 18 (01) : 51 - 60

← 1 2 3 →